Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of Toll-Like Receptor Gene Polymorphisms with Tuberculosis in HIV-Positive Participants. | Epigenomes | 2023 | 37606452 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods. | J Chem Inf Model | 2023 | 37602861 | PubTator, text mining | PubMed |
| The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain. | Blood Cancer J | 2023 | 37591861 | PubTator, text mining | PubMed |
| An interaction between OTULIN and SCRIB uncovers roles for linear ubiquitination in planar cell polarity. | Dis Model Mech | 2023 | 37589075 | PubTator, text mining | PubMed |
| Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights. | Onco Targets Ther | 2023 | 37583706 | PubTator, text mining | PubMed |
| An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory Processes. | Int J Mol Sci | 2023 | 37569837 | PubTator, text mining | PubMed |
| Lipopolysaccharide Tolerance in Human Primary Monocytes and Polarized Macrophages. | Int J Mol Sci | 2023 | 37569572 | PubTator, text mining | PubMed |
| The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants. | Sci Rep | 2023 | 37567916 | PubTator, text mining | PubMed |
| Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review. | Allergy Asthma Clin Immunol | 2023 | 37559153 | PubTator, text mining | PubMed |
| The Interaction between Macrophages and Triple-negative Breast Cancer Cells Induces ROS-Mediated Interleukin 1α Expression to Enhance Tumorigenesis and Metastasis. | Adv Sci (Weinh) | 2023 | 37551997 | PubTator, text mining | PubMed |
| The interleukin-1 receptor type-1 in disturbed flow-induced endothelial mesenchymal activation. | Front Cardiovasc Med | 2023 | 37539090 | PubTator, text mining | PubMed |
| Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1. | iScience | 2023 | 37534161 | PubTator, text mining | PubMed |
| Immunoinformatic and reverse vaccinology-based designing of potent multi-epitope vaccine against Marburgvirus targeting the glycoprotein. | Heliyon | 2023 | 37534001 | PubTator, text mining | PubMed |
| First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults. | Eur J Drug Metab Pharmacokinet | 2023 | 37532923 | PubTator, text mining | PubMed |
| In silico identification of potential miRNAs -mRNA inflammatory networks implicated in the pathogenesis of COVID-19. | Hum Gene (Amst) | 2023 | 37520333 | PubTator, text mining | PubMed |
| The Potential of Probiotics as Ingestible Adjuvants and Immune Modulators for Antiviral Immunity and Management of SARS-CoV-2 Infection and COVID-19. | Pathogens | 2023 | 37513775 | PubTator, text mining | PubMed |
| Simulation-Based Research on Phytoconstituents of Embelia ribes Targeting Proteins with Pathophysiological Implications in Rheumatoid Arthritis. | Life (Basel) | 2023 | 37511842 | PubTator, text mining | PubMed |
| Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management. | Int J Mol Sci | 2023 | 37511551 | PubTator, text mining | PubMed |
| MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer. | Cells | 2023 | 37508580 | PubTator, text mining | PubMed |
| Management of Rheumatoid Arthritis: Possibilities and Challenges of Mesenchymal Stromal/Stem Cell-Based Therapies. | Cells | 2023 | 37508569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=17